Depressionen: Psychodroge Psilocybin in Phase-2-Studie wirksam New York – Die einmalige Einnahme von Psilocybin, dem psychedelischen Inhaltsstoff bestimmter Pilzarten, hat in einer Phase-2-Studie therapieresistente Depressionen gelindert. Der Herst…

Moving Past Mysticism in Psychedelic Science James W. Sanders and Josjan Zijlmans ACS Pharmacology & Translational Science 2021 4 (3), 1253-1255  DOI: 10.1021/acsptsci.1c00097  https://pubs.acs.org/doi/10.1021/acspts…

GLOBAL DRUG SURVEY (GDS) 2021 KEY FINDINGS REPORT WINSTOCK AR, MAIER LJ, ZHUPARRIS A, DAVIES E, PULJEVIC C, KUYPERS KPC, FERRIS JA & BARRATT MJ. (2021).  https://www.globaldrugsurvey.com/wp-content/uploads/2021/12/Report2021_global.pdf

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.  Doss, M.K., Považan, M., Rosenberg, M.D. et al.  Transl Psychiatry 11, 574 (2021). doi.org/10.1038/s41398-021-01706-y https://rdc…

GDS2022: The 10th anniversary survey: Could you be participant 1 million? Professor Adam Winstock, Dr Monica Barratt, Dr Emma Davies & Associate Professor Jason Ferris – GDS Core Research Team, on behalf of all at GDS  Happy birthday to u…

Fitzgerald PJ. Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.  Fitzgerald PJ.  Int J Mol Sci. 2021 Oct 2;22(19):10706. doi: 10.3390/ijms221910706. PMID: 34639047; PMCID: PMC8509043. h…